Objective The plasma eicosapentaenoic acid to arachidonic acid ratio (EPA/AA), which is determined only by dietary intake, has been attracting attention as a new risk marker for coronary artery disease (CAD). A Japanese inland prefecture, Tochigi, ranks higher mortality rate from CAD and lower seafood consumption, compared to other prefectures. The aim of this study was to investigate the EPA/AA ratio in residents of Tochigi prefecture. Methods We measured the EPA/AA ratio in patients undergoing diagnostic coronary angiography, because of suspicion for having CAD, all of whom were residents of Tochigi prefecture or its bordering area. Patients A total of 428 patients were enrolled in 5 centers. Results The median value of the EPA/AA ratio in the study patients was 0.37, which seems to be lower than the value of the whole Japan. The EPA/AA ratio was similar in patients with and without CAD. Female patients had lower EPA/AA ratios than male patients. When subjects were divided into 10-year age groups, 30-to 39-year-old male and female patients displayed similar EPA/AA ratios. However, the ratios of 50-to 59-year old female patients (p=0.001) and 60-to 69-year old female patients (p=0.034) were significantly lower than those of age-matched male patients. Conclusion In female residents of Tochigi prefecture, and particularly in menopausal female patients suspected of CAD, the EPA/AA ratio might be lower than male patients. EPA intake can help prevent cardiovascular events, especially in menopausal female residents of an area where the fish intake is low.
Introduction
Recent advances in drugs such as statins or reninangiotensin system (RAS) inhibitors, which block the effects of risk factors such as dyslipidemia or hypertension, represent one of the greatest success stories in primary as well as secondary prevention of cardiovascular disease. Statins and RAS inhibitors have pleiotropic effects and accordingly, the efficacy of these drugs in reducing the risk of cardiovascular events is multidimensional (1) . Various large-scale interventional studies have indicated that, together with other pleiotropic effects, the efficacy of statins in reducing low density lipoprotein (LDL) cholesterol levels and the efficacy of RAS inhibitors in lowering blood pressure could allow these drugs to play the main role in today's medical treatment of coronary artery disease. However, management of diabetes, and aggressive antihypertensive and lipid-lowering treatments can only inhibit 30-40% of cardiovascular events (2) (3) (4) . Therefore, constant efforts are needed to identify and utilize new risk markers to further decrease the occurrence of cardiovascular events.
The 1970's epidemiological study of Caucasians and Inuits in Denmark reported that the Inuits, whose diets consist primarily of fish, had a significantly lower incidence of myocardial infarction than the Caucasians, whose diets are high in dairy consumption (5) . These results are thought to be due to the high concentration of n-3 fatty acids found in the Inuit's main food source, seals that feed on fish. Since then, there have been numerous publications suggesting the benefits of a seafood diet (6, 7) . In particular, it has become clear that the ratio of eicosapentaenoic acid (EPA), a n-3 fatty acid, to arachidonic acid (AA), a n-6 fatty acid, is important (8) . The plasma EPA/AA ratio has recently been focused on as a new risk marker for coronary artery disease (CAD) (9) . Neither EPA, which is a polyunsaturated fat, nor AA, which is an essential fatty acid, can be synthesized in the human body, and thus only dietary intake can increase the concentration of these molecules in the blood.
Tochigi prefecture is an inland prefecture in Japan, and ranks significantly lower than the national average in the purchased amount of seafood, according to the "Survey by items of household expenditure in the prefectural capital cities and designated cities" conducted by the Census and Statistics Department at the Ministry of Internal Affairs and Communications (http://www.stat.go.jp/data/kakei/5.htm). Also, according to the Japanese Health, Labour and Welfare Ministry, Tochigi prefecture has a higher mortality rate from CAD when compared to other prefectures. During 2006, in particular, the mortality rate from myocardial infarction in women of Tochigi prefecture was the highest in the nation (http://www.mhlw.go.jp / toukei / saikin / hw / jinkou / other / 10 sibou/index.html). Our group is conducting the Tochigi Ratio of EPA/AA Trial in Coronary Artery Disease, in which we assess the efficacy of intervention with EPA agents in patients with CAD living in Tochigi prefecture, and especially in those with a low EPA/AA ratio. Prior to the interventional trial, we investigated the baseline EPA/AA ratios in residents of Tochigi prefecture, focusing specifically on gender differences.
Materials and Methods

Study design
This study was conducted between February and June 2010, and was based on the ethical research guidelines at each of the 6 candidate centers in Tochigi prefecture: Dokkyo Medical University Hospital, Sano Kosei Hospital, Shimotsuga General Hospital, Haga Red Cross Hospital, Ashikaga Red Cross Hospital and Nikko Medical Center, Dokkyo Medical University. For this study, we recruited 428 consecutive patients (327 males, 101 females, mean age 66.2±10.8 yrs), who underwent diagnostic cardiac catheterization, including coronary angiography, at one of the 5 centers. Atherosclerotic CAD patients were divided into singlevessel and multi-vessel disease groups after detection of organic stenotic lesions in any coronary branch using coronary angiography. In the case of patients without organic coronary artery stenosis who underwent the acetylcholine test, those with a positive acetylcholine test were diagnosed with vasospastic angina. Patients with a negative acetylcholine test were diagnosed with chest pain syndrome. Patients who did not have vasospastic angina or chest pain syndrome were diagnosed with arrhythmia, valvular heart disease, cardiomyopathy, or another condition.
In all 428 patients, we measured the plasma concentrations of EPA and AA in the venous blood taken after fasting in the early morning on the day of the coronary angiography, and then calculated the EPA/AA ratio. We excluded patients with acute coronary syndrome, patients who took EPA as an agent or dietary supplement and hemodialysis patients. We assessed the co-incidence of conventional risk factors such as hypertension, dyslipidemia, diabetes and a current smoking habit. The levels of hemoglobin A1c (HbA1c), LDL-cholesterol, high density lipoprotein (HDL)-cholesterol, triglycerides (TG), and uric acid (UA) were measured in the blood samples that were used for the EPA and AA measurements. The patients were categorized into two groups according to sex. For the purpose of comparison, the male and female groups were then divided into subgroups according to age, with each subgroup spanning a ten-year range.
Statistical analysis
Data were expressed as a mean value ± standard deviation. Two groups were compared using the Student's unpaired t test for continuous variables and the chi-square test for categorical variables. Multi-group comparisons were performed using the one-way analysis of variance followed by the post-hoc Fisher's protected least significant difference test. Statistical significance was defined as p<0.05. All statistical analyses were performed using the statistical software, StatMate IV (Atoms).
Results
The patient demographics and baseline characteristics for all 428 cases are shown in Table 1 . Hypertension, diabetes, hyperlipidemia, and smoking were present in 311 (73%), 186 (43%), 280 (65%), and 142 (33%) of patients, respectively. Of the 428 patients, 328 (77%) had angiographyverified CAD. Single-vessel and multi-vessel disease were diagnosed in 135 (32%) and 167 (39%) of patients, respectively. Vasospastic angina was detected in 26 patients (6%), and the remaining 100 patients (23%) were diagnosed with non-CAD conditions including chest pain syndrome, ar- The mean value of EPA/AA ratio for all patients was 0.49±0.39, and the median value was 0.37. A comparison of risk factors according to gender revealed that male patients had higher rates of diabetes (p=0.041) and current smoking (p<0.001) than female patients, but there were no significant differences in the values for HbA1c, LDL-cholesterol, HDLcholesterol, TG, and UA. The mean EPA/AA ratio of female patients (0.42±0.34) was significantly lower than the mean ratio of male patients (0.51±0.40, p=0.043) ( Table 2 ). When patients were divided into subgroups based on age, the plasma EPA level tended to be lower in female, compared to male in each groups. Especially the levels of the females was significantly lower than that of the males in the limited group aged 50-to 59-year-old (48.6±27.8 vs. 27.2±11.0 μg/ dL, p=0.0001). In contrast the plasma AA level of the females was significantly higher than that of the males in the groups aged 50-to 59-year-old (153.0±39.6 vs. 179.4±55.4 μg/dL, p=0.038) and 60-to 69-year-old (141.4±38.6 vs. 159.3±34.7 μg/dL, p=0.01) (Table 3) . Overall, the EPA/AA ratios tended to be lower in younger subjects, compared to older subjects. The EPA/AA ratios of 30-to 39-year-old females tended to be higher than that of males of the same age. Males and females aged 40-to 49-year old had similar EPA/AA ratios, but 50-to 79-year-old females had lower EPA/AA ratios than their male counterparts. Specifically, the mean EPA/AA ratio of 50-to 59-year-old females (0.17± 0.10) was significantly lower than the mean ratio of females of the same age (0.37±0.33, p=0.001); the EPA/AA ratios were also significantly different between the sexes in 60-to 69-year-old patients (females, 0.44±0.29; males 0.58±0.42; p=0.034) (Fig. 1) . When categorizing the subjects into two groups and comparing the EPA/AA ratios of patients with conventional coronary risk factors to the ratios of patients without them, there were no differences among the hypertension, diabetes, hyperlipidemia, obesity, family history and current smoking groups (Table 4) . Finally, the EPA/AA ratios were similar among the non-CAD, vasospastic angina, single-vessel CAD, and multi-vessel CAD patient groups (Fig. 2) .
Discussion
Our study was limited to patients who underwent diagnostic cardiac catheterization including coronary angiogra- Figure 1 . Comparison of the EPA/AA ratios between males and females, divided into subgroups that span 10 years. Overall, the EPA/AA ratios tended to be lower in younger subjects, compared to older subjects. Among 30-to 39-year-old patients, the EPA/AA ratios of women tended to be higher than the ratios of men. The EPA/AA ratios of men and women between 40 to 49 years of age were similar. Women between 50 to 70 years of age had lower ratios than their male counterparts. Specifically, women in the 50-to 59-year-old and 60-to 69-year-old subgroups had significantly lower EPA/AA ratios compared to men of the same age. phy, and this inclusion criterion resulted in the enrollment of both CAD and non-CAD patients. Most patients were undergoing strict treatments for hypertension, diabetes, and hyperlipidemia. Thus, in both the male and female groups, the glucose metabolism and lipid profiles, such as HbA1c and LDL-cholesterol levels, were managed relatively well. In addition, our study subjects included only residents of Tochigi prefecture or its bordering areas, where there is little consumption of seafood. The Kumihama study investigators previously reported that the EPA/AA ratio was higher and the incidence of CAD were lower in the people living in fishing areas, compared to those living in mercantile or farming areas (10) . Although there are no limitations of seafood consumption nowadays when distribution system is highly developed, the taste for seafood may be habitually different in seacoast area and inland area.
Many international publications have addressed the correlation between the incidence of cardiovascular events and intake of n-3 polyunsaturated fatty acids (PUFA). The findings from a large-scale interventional study that was conducted in Japan, the Japan Eicosapentaenoic acid Lipid Intervention Study (JELIS) (11) , have provided information about the effectiveness of a high-grade EPA agent. In the JELIS study, the high-grade EPA agent significantly reduced the incidence of cardiovascular events in high-risk patients. Furthermore, a subanalysis of JELIS revealed that a lower EPA/AA ratio significantly raised the risk of incidence (12) . The average value of EPA/AA ratio before the administration of the EPA agent was 0.6 in the JELIS study, which included patients from the whole of Japan. In contrast, the average value of EPA/AA ratio of our study subjects were 0.49, which is lower than the value determined in JELIS. The current domestic median value of EPA/AA ratio is unclear but is assumed to be lower, compared to the value at JELIS's era, because of changes in lifestyle, especially dietary habit. Recently, Domei et al. (13) demonstrated in consecutive 284 patients undergoing percutaneous coronary intervention (PCI) that the incidence of subsequent major adverse cardiac events was strongly associated with the level of EPA/AA ratio. Even in their study subjects, all of whom seemed to be a high risk population as requiring PCI, the median value of EPA/AA ratio was 0.4. Therefore, the EPA/ AA value of our study was 0.37 and seems to be still low even at the present day.
In our study, the EPA/AA ratio was similar among non-CAD, vasospastic angina, single-vessel CAD and multivessel CAD patient groups. This result suggests that the lower EPA/AA ratios observed in the cohort of this study may be independent of at least the presence or the severity of CAD. Further investigation would be required to assess whether the low EPA/AA is a risk marker for CAD. Instead, the lower EPA/AA ratios observed in the residents of Tochigi prefecture may be associated with the fact that they consume less fish.
Although it is well known that there is a gender difference in the incidence of CAD and that the incidence is higher in males (14, 15) , it is not clear whether the gender difference is related to sex hormones or to the living environment. According to the analysis of the relationship between menopause and cardiovascular events in the Framingham study, the incidence of CAD in postmenopausal women is much higher than in premenopausal females, even after age correction (16) . Large-scale clinical trials for estrogen replacement therapy were conducted on postmenopausal females, but these trials failed to show an effect of the estrogen therapy on reducing the incidence of coronary artery events for primary as well as secondary prevention (17) (18) (19) (20) . Yanagisawa et al. (21) reported that there is no gender difference in the levels of EPA/AA ratio and that the levels tended to increase with age in healthy Japanese subjects living in urban area. Also in our study cohort, the EPA/AA ratios tended to be lower in younger subjects, compared to older subjects. However, in our study, female patients had significantly lower EPA/AA ratios than male patients. By comparing the results in each age group, we determined that the EPA/AA ratios of 50-to 59-year-old and 60-to 69-yearold female patients were lower than the ratios of similarlyaged male patients. These results suggest that females of these ages in Tochigi prefecture may not ingest as much EPA. However, our findings could also be related to the female-specific metabolic changes caused by menopause. The implication of n-3 PUFA for estrogen metabolism has been previously reported. The n-3 PUFA inhibits the proliferation of human breast cancer cell by affecting on the proapoptotic signaling of estrogen in breast cancer cell (22) . The oxidative metabolism of estrogen is catalyzed by hepatic cytochrome P450 (CYP450) predominantly. Dietary fish oil increases the concentration of CYP450 and some subtypes of CYP450 in rats (23) . In addition, the n-3 PUFA supplementation may decrease the metabolism of estradiol (24) . On the other hand, α-linolenic acid is converted to long chain n-3 PUFA such as EPA and docosahexiaenoic acid (DHA) by desaturase and elongase enzymes in the liver. It has been evident that the concentrations of long chain n-3 PUFA in rat plasma and tissues are positively associated with circulating concentration of estrogen and progesteron, and negatively associated with concentration of testosterone. The evidence suggests that sex hormones may act to modify plasma and tissue n-3 PUFA content, possibly by altering the expression of desaturase and elongase enzymes (25) .
The mechanisms by which estrogen lowers LDLcholesterol levels and raises HDL-cholesterol levels are well known. It is also well known that although the incidence of hypercholesterolemia is higher in men than in females under 40 years old, this trend reverses as females enter menopause and estrogen production decreases. The gender difference in the mortality rate from CAD lessens at menopause and disappears when measured in people older than 80 years. This fact suggests that, in females, the metabolism of essential fatty acids may also be affected when their bodies change due to menopause. Changes in fatty acid metabolism in menopausal females could perhaps be correlated with our observations of gender differences in the EPA/AA ratio in patients between the ages of 50 and 70. If the gender difference of EPA/AA ratio found in subjects in their 50s and 60s in this study results from lower intake of n-3 PUFA and greater intake of n-6 PUFA, we need to encourage women to actively consume EPA as well as dietary restriction of AA. This is particularly important for menopausal females who live in regions such as Tochigi prefecture, where there is a high rate of mortality due to myocardial infarction. It is possible that administration of EPA agents to menopausal females with low EPA/AA ratios, when coupled with intervention against conventional risk factors, may produce improvements in the CAD incidence rate that were not previously achieved with estrogen replacement therapy.
Conclusion
EPA/AA ratios in female residents of Tochigi prefecture, an inland prefecture in Japan, were significantly lower, especially in menopausal females, when compared to male residents. EPA agents are known to reduce the incidence of cardiovascular events; however, the concentration of EPA, an essential fatty acid, in the bloodstream of the human body can only be increased through dietary intake. Therefore, increased EPA intake through a fish diet or EPA agents and restrict of AA intake can help prevent cardiovascular events, especially in female residents of areas where the fish intake is low.
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